Company · Ownership research

Entrada Therapeutics, Inc. TRDA

CIK 0001689375

Form 4 transactions dated Sep 1, 2023 to Sep 25, 2026, as reported to the SEC.

Insider trading Initial holdings Institutional holders

This page lists 30 of 50 rows; the complete set is available through the API.

Insider filings on file run through 2026-09-09.

Some filings are submitted jointly by several insiders. The SEC form does not apportion the reported figures between them, so results include every joint filer.

Insider purchases & sales

Purchased: $2.65M
Sold: $21.56M

Sep 1, 2023 – Sep 9, 2026
Available records · partial months are marked ·

Insiders in this window

202410 of 30 preview events · 50 available in 2024

Date	Insider	Activity	Trade value (USD)	% of prior holding
2024-12-11	MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 GP LLC · MPM BioVentures 2018 LLC 10% owner	Sale	$440.75K 21,787 shares sold	Unavailable Indirect holding	▾
2024-12-11	GADICKE ANSBERT · EVNIN LUKE · Foley Todd · MPM BioVentures 2014, L.P. · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC 10% owner	Sale	$440.75K 21,787 shares sold	Unavailable Indirect holding	▾
2024-12-10	MPM BIOVENTURES 2018, L.P. · MPM BioVentures 2018 GP LLC · MPM BioVentures 2018 LLC 10% owner	Sale	$476.36K 22,935 shares sold	Unavailable Indirect holding	▾
2024-12-10	GADICKE ANSBERT · EVNIN LUKE · Foley Todd · MPM BioVentures 2014, L.P. · MPM BioVentures 2014 (B), L.P. · MPM Asset Management Investors BV2014 LLC · MPM BIOVENTURES 2018 (B), L.P. · MPM ASSET MANAGEMENT INVESTORS BV2018 LLC · MPM BioVentures 2014 LLC · MPM BioVentures 2014 GP LLC 10% owner	Sale	$476.36K 22,935 shares sold	Unavailable Indirect holding	▾
2024-12-03	Sethuraman Natarajan President, Research & Develop.	Sale10b5-1 footnote	$235.79K 11,703 shares sold	7.47% sold Direct holding	▾
2024-12-02	WENTWORTH KORY JAMES Chief Financial Officer	Sale10b5-1 footnote	$99.98K 5,000 shares sold	6.34% sold Direct holding	▾
2024-12-02	Sethuraman Natarajan President, Research & Develop.	Sale10b5-1 footnote	$82.83K 4,088 shares sold	2.54% sold Direct holding	▾
2024-11-29	WENTWORTH KORY JAMES Chief Financial Officer	Sale10b5-1 footnote	$19.97K 1,000 shares sold	1.34% sold Direct holding	▾
2024-11-29	Sethuraman Natarajan President, Research & Develop.	Sale10b5-1 footnote	$2.00K 100 shares sold	0.06% sold Direct holding	▾
2024-11-13	Sethuraman Natarajan President, Research & Develop.	Sale10b5-1 footnote	$54.11K 2,700 shares sold	1.65% sold Direct holding	▾

Showing 30 / 50 record groups in 2024. The complete set is available through the API.

Entrada Therapeutics, Inc. · TRDA

Follow the people behind the trades.

Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and reach other datasets through the Akkru API.

Download CSV
Earlier filings
Advanced screening & filtering
API & AI access

Already have an account?

＋ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account. For the year shown, this page lists 30 of 50 purchase / sale groups and 30 of 47 other groups; the totals and the monthly series cover the whole window.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

list_insider_transactions
{"ticker":"TRDA","transaction_code":["P","S"],"transaction_form_type":"4","page_size":20}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint: https://api.akkrudata.ai/mcp
API / MCP documentation: /documents
llms.txt: /llms.txt

Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

Non-cancelled, non-derivative purchase (P) and sale (S) rows dated inside the public window, as reported. Includes open-market and private transactions. Data after the latest filing is not asserted complete and is not zero-filled. A grouped event shares filing, transaction date, security, code, direction, ownership bucket and source. Derivative groups also match underlying security, exercise price, exercise/expiration dates and footnote references. Reported rows are retained; P/S price lots can be grouped. Post-transaction balances are never summed.